Biotecnología

Biotecnología

IMPRESCINDIBLE

Tecno INTI: se presentaron más de 300 investigaciones estratégicas impulsadas por trabajadoras y trabajadores de todo el país | Argentina.gob.ar

03/10/2022 - En el marco de los eventos de celebración del 65° aniversario del instituto, se realizó una nueva edición de las Jornadas de Desarrollo, Innovación y Transferencia Tecnológica, en las que se abordaron más de 10 líneas de trabajo, entre las que se destacaron simposios de especialistas y exposiciones de proyectos destacados.

IMPRESCINDIBLE

“El estudio del microbioma ayudará a diseñar terapias para las enfermedades neurodegenerativas”

13/10/2022 - “El estudio del microbioma ayudará a diseñar terapias para las enfermedades neurodegenerativas” ¿Existe el llamado eje intestino-cerebro?. Esta doctora en Biotecnología indaga sobre esta relación y sus posibles efectos en el desarrollo de dolencias neurodegenerativas. Su proyecto ha sido premiado en la última edición del programa de Mujer y Ciencia de L'Oréal-Unesco.

IMPRESCINDIBLE

Más de 20 referentes industriales de UIA Joven conocieron de cerca las capacidades tecnológicas del INTI | Argentina.gob.ar

03/10/2022 - Un grupo de dirigentes sub-40, encabezado por el empresario textil Tomás Karagozian, se reunieron con el presidente del instituto, Ruben Geneyro, y visitaron 12 sectores del organismo en su sede de San Martín, provincia de Buenos Aires. El Centro de Biotecnolog{ia Industrial fue visitado por el Laboratorio Craveri, repreentado por Laura Craveri y Diego Dominici

IMPRESCINDIBLE

Fujifilm Cellular Dynamics Names Ilyas Singeç as CSO

20/09/2022 - 09.16.22 Fujifilm Cellular Dynamics, a global developer and manufacturer of human induced pluripotent stem cells (iPSCs), has appointed Ilyas Singeç, MD, as chief scientific officer effective September 12. In this newly created strategic role, Dr. Singeç will define the company’s future iPSC technological pipeline. In his role as part of the company’s executive leadership team, he will also help drive business strategy with the goal of transforming scientific research and healthcare by using iPSC technologies.

UBA, crean biotinta con aceite de cannabis para restaurar tejidos
03/12/2022 - Desarrollan en Argentina biotinta que contiene aceite de cannabis para restaurar tejidos
FDA Roundup: November 29, 2022
30/11/2022 - The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.
Integreon Global Appoints Michael Hays as President
30/11/2022 - Replaces Maurice Barakat, who will assume the role of Executive Chairman and CEO.
Lonza, AbTis Partner to Extend Bioconjugation Capabilities
30/11/2022 - To implement AbTis’ AbClick platform into Lonza’s bioconjugation toolbox.
Aptamer Group Opens New State-of-the-Art Facilities
30/11/2022 - New site will help to expand capacity of Aptamer’s Optimer platform to deliver novel binders for the bioprocessing, diagnostic, and drug development sectors.
Immutep Enters Clinical Trial Collaboration Merck KGaA and Pfizer
30/11/2022 - To evaluate new combination study of its first-in-class LAG-3 candidate, eftilagimod alpha, and avelumab to treat urothelial cancer.
C4X Discovery, AstraZeneca Enter Potential $402M COPD Alliance
30/11/2022 - The companies will work to develop C4XD’s NRF2 Activator program in COPD and other inflammatory and respiratory illnesses.
BigHat Biosciences, Merck Enter AI Research Collaboration
30/11/2022 - To optimize up to three proteins by leveraging BigHat’s platform to synthesize, express, purify, and characterize molecules.
Biocon Completes Acquisition of Viatris' Global Biosimilars Business
30/11/2022 - Creates an integrated, leading global biosimilars enterprise with eight commercialized products.
c16 Biosciences gears up to launch fermentation-based palm oil replacement for personal care in 2023, food in 2024
30/11/2022 - Utilized in everything from lipsticks and moisturizers to baked goods and confectionery, palm oil comes with environmental and societal costs â displacing tropical forests across Asia, Latin America...
AstraZeneca to Acquire Neogene Therapeutics in $320M Deal
30/11/2022 - Provides access to next-generation T-cell receptor therapies with promising potential for targeting solid tumors.
Soup-To-Nuts Podcast: Emerging flavor trends cater to comfort, nostalgia & whimsy
30/11/2022 - The stressful one-two punch of pandemic lockdowns followed by runaway inflation has many consumers looking for comfort and escapism from their food and beverages, which industry leaders say is...
Quotient Sciences Partners with Emplicure to Manufacture and Study EMPLI03
30/11/2022 - Emplicure is developing EMPLI03 as an oral buccal tablet with extended-release properties intended for the treatment of moderate to severe pain.
WATCH: Next-gen biomanufacturing… from lower-cost feedstocks for precision fermentation to ‘cell-free’ approaches
30/11/2022 - Biomanufacturing everything from âanimal-freeâ dairy and egg proteins and high-intensity natural sweeteners to heat-and pH-stable red pigments is a hot topic in food tech. But which microbes will...
Andelyn Biosciences to Bring First Gene Therapy for Treatment of INAD to Clinical Trials
30/11/2022 - Infantile Neuroaxonal Dystrophy (INAD) is a rare inherited neurological disorder.
Hershey renews partnership with The Grinch to bring festive joy this season
30/11/2022 - Hershey has announced its holiday lineup for winter 2022 with classic festive favourites including Grinch-themed Hersheyâs KISSES and Reeseâs Peanut Butter Trees returning once again, and brand-new...
Avectas Expands Collaboration with CCRM and OmniaBio Inc.
30/11/2022 - Will enable the development of gene-edited induced pluripotent stem cells using Avectas' non-viral cell engineering platform, SOLUPORE.